March 11, 2018
A trial is underway to evaluate the use of dual chimeric antigen receptor T-cell immunotherapy for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia.
February 6, 2018
In the future, fighting cancer may no longer mean grueling chemotherapy, but genetically altered immune systems that can be “remote controlled.”
January 31, 2018
Over the last several years, immunotherapy has emerged as a promising alternative to traditional forms of cancer treatment.
January 29, 2018
Seattle Children’s Hospital launched a first-of-its-kind high-risk leukemia program, with the goal of redefining care for children with leukemia who did not respond to or relapsed after treatment.